Pandemic Leads to Delays in Crucial Early Cancer Screening Tests - Targeted Oncology

Clayton Lau, MD, discusses the consequences of patients delaying cancer screenings due to fears of COVID-19.

Clayton Lau, MD, chief of the division of urology and urologic oncology, director of the prostate cancer program, and head of retroperitoneal surgery at City of Hope, discusses the consequences of pa… [+1948 chars]

full article...